Glaxosmithkline

GlaxoSmithKline (GSK)

Company name:Glaxosmithkline
Company Description:A group engaged in the creation; discovery; development; manufacture and marketing of pharmaceutical and consumer health-related products
EPIC:GSKTrading Currency:GBX
Market Sector:FE00ISIN:GB0009252882
Market Segment:SET0Share Type:DE
WWW Address:http://www.gsk.com/Description:ORD 25P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 1,708.50 .advfn.com/imagesnew/2/gb/down -13.5 [-0.78] 1,710.00 1,710.50 1,720.00 1,721.50 1,708.50 5,105,868
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 83,894.08 4,910.39 1.22 18.80 80.00 90.88 4.68 1,735.50 - 1,363.00

GlaxoSmithKline Key Figures

(at previous day's close)
Market Cap.83,894.08m
Shares In Issue4,910.39m
Prev. Close1,722.00
PE Ratio90.88 
Dividend Yield4.68%
EPS - basic18.80p
Dividend PS80.00p
Dividend Cover0.24 
Cash Flow PS132.31p
Return On Equity (ROE)81.14%
Operating Margin6.95%
PEG Factor-1.02 
EPS Growth Rate-89.21%
Dividends PS Growth Rate-20.00%
Net Debt49,221.00m
Gross Gearing91.60%
Quick Assets15,738.00m
Net Working Capital1,839.00m
Intangibles / Fixed Assets64.70%
Turnover PS567.96p
Pre-Tax Profit PS39.49p
Retained Profit PS-80.20p
Cash PS99.73p
Net Cash PS-287.23p
Net Tangible Asset Value PS *-480.96p
Net Asset Value PS101.07p
Spread0.50 (0.03%) 

GlaxoSmithKline Balance Sheet

LSE:GSK:Liabilities+EQLSE:GSK:Assets

Share Price Performance

Sample Period HighLow
1 week1,724.501,676.00
4 weeks1,724.501,626.50
12 weeks1,724.501,543.50
1 year1,735.501,363.00

Share Price Chart (5 years)

GlaxoSmithKline Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week1,685.0023.501.391,676.0010.43-
4 weeks1,626.5082.005.041,626.5010.64-
12 weeks1,680.5028.001.671,543.5010.21-
26 weeks1,549.00159.5010.301,511.509.10-
1 year1,397.50311.0022.251,363.009.32-
3 years1,564.50144.009.201,227.509.11-
5 years1,452.00256.5017.671,227.508.41-

GlaxoSmithKline Key Management Ratios

GlaxoSmithKline Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio38.86 
PE Ratio90.88 
Tobin's Q Ratio 1.49 
Tobin's Q Ratio (excl. intangibles)2.54 
Dividend Yield4.68%
Market-to-Book Ratio74.64 
Price-to-Pre-Tax Profit PS43.27 
Price-to-Retained Profit PS-21.30 
Price-to-Cash Flow PS12.91 
Price-to-Sales PS3.01 
Price-to-Net Tangible Asset Value PS-4.24 
Price-to-Cash PS17.13 
Net Working Capital PS37.45 
Price Pct to Working Capital PS45.62%
Earnings Yield1.10%
Average PE28.77 
Years in average5 
PE to PE average315.82%

GlaxoSmithKline Financial Ratios

(Leverage Ratios)
Debt Ratio87.62%
Debt-to-Equity Ratio7.08 
Debt-to-Equity Ratio (excl. Intgbl)-1.78 
Debt-to-Equity Market Value0.42 
Net Gearing83.31%
Net Gearing (excl. Intangibles)143.33%
Gross Gearing91.60%
Gross Gearing (excl. Intangibles)157.59%
Gearing Under 1 Year32.16%
Gearing Under 1 Year (excl. Intgbl)55.33%
Assets/Equity11.90 
Cash/Equity98.67 
(Liquidity Ratios)
Net Working Capital to Total Assets3.11%
Current Ratio1.10 
Quick Ratio (Acid Test)0.83 
Liquidity Ratio0.26 
Cash & Equiv/Current Assets23.50%
(Solvency Ratios)
Enterprise Value117,953.08m
CFO/Sales0.23 
CFO/Attributable Profit7.12 
CFO/Assets0.11 
CFO/Debt0.12 
Total Debt/Equity Market Value0.65 
Total Debt/Sales1.94 
Total Debt/Pre-Tax Profit27.91 
Total Debt54,118.00m
Total Debt/Net Current Assets29.43%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs9 
Beta (60-Mnth)Beta (36-Mnth)
1.22451.4908
Alpha (60-Mnth)Alpha (36-Mnth)
-0.0039-0.0024

GlaxoSmithKline Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)4.84%
Return On Assets (ROA)1.62%
Net Profit Margin3.27%
Assets Turnover0.50 
Return On Equity (ROE)81.14%
Return On Investment (ROI)2.28%
Dividend Payout Ratio425.53%
Plowback Ratio-325.53%
Growth from Plowback Ratio-95.19%
Net Income Of Revenues-14.12%
(Asset Utilisation Multiples)
Shareholders Equity Turnover8.94 
Fixed Assets Turnover0.77 
Current Assets Turnover1.39 
Net Working Capital Turnover 
Inventory Turnover5.68 
(Other Operating Ratios)
Total Assets-to-Sales2.02 
Debtors-to-Sales34.65%
Debt Collection Period126.47Days

GlaxoSmithKline Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
08 Feb 2017FinalGBX23.0031/12/201531/12/201623/02/201724/02/201713/04/201780.00
26 Oct 2016QuarterlyGBX19.0031/12/201531/12/201603/11/201604/11/201612/01/2017-
27 Jul 2016QuarterlyGBX19.0031/12/201531/12/201611/08/201612/08/201613/10/2016-
27 Apr 2016QuarterlyGBX19.0031/12/201531/12/201612/05/201613/05/201614/07/2016-
03 Feb 2016FinalGBX23.0031/12/201431/12/201518/02/201619/02/201614/04/2016100.00
03 Feb 2016SpecialGBX20.0031/12/201431/12/201518/02/201619/02/201614/04/2016-
19 Oct 2015QuarterlyGBX19.0031/12/201431/12/201512/11/201513/11/201514/01/2016-
29 Jul 2015QuarterlyGBX19.0031/12/201431/12/201513/08/201514/08/201501/10/2015-
06 May 2015QuarterlyGBX19.0031/12/201431/12/201514/05/201515/05/201509/07/2015-
04 Feb 2015FinalGBX23.0031/12/201331/12/201419/02/201520/02/201509/04/201580.00
22 Oct 2014QuarterlyGBX19.0031/12/201331/12/201406/11/201407/11/201408/01/2015-
24 Jul 2014QuarterlyGBX19.0031/12/201331/12/201406/08/201408/08/201402/10/2014-
30 Apr 2014QuarterlyGBX19.0031/12/201331/12/201414/05/201416/05/201410/07/2014-
05 Feb 2014FinalGBX23.0031/12/201231/12/201319/02/201421/02/201410/04/201478.00
23 Oct 2013QuarterlyGBX19.0031/12/201231/12/201313/11/201315/11/201309/01/2014-
24 Jul 2013QuarterlyGBX18.0031/12/201231/12/201307/08/201309/08/201303/10/2013-
24 Apr 2013QuarterlyGBX18.0031/12/201231/12/201308/05/201310/05/201311/07/2013-
06 Feb 2013FinalGBX22.0031/12/201131/12/201220/02/201322/02/201311/04/201374.00
31 Oct 2012QuarterlyGBX18.0031/12/201131/12/201214/11/201216/11/201203/01/2013-
25 Jul 2012QuarterlyGBX17.0031/12/201131/12/201208/08/201210/08/201204/10/2012-
25 Apr 2012QuarterlyGBX17.0031/12/201131/12/201209/05/201211/05/201205/07/2012-
07 Feb 2012SpecialGBX5.0031/12/201031/12/201115/02/201217/02/201212/04/2012-
07 Feb 2012FinalGBX21.0031/12/201031/12/201115/02/201217/02/201212/04/201275.00
26 Oct 2011InterimGBX17.0031/12/201031/12/201102/11/201104/11/201105/01/2012-
26 Jul 2011InterimGBX16.0031/12/201031/12/201103/08/201105/08/201106/10/2011-
27 Apr 2011InterimGBX16.0031/12/201031/12/201104/05/201106/05/201107/07/2011-
03 Feb 2011FinalGBX19.0031/12/200931/12/201009/02/201111/02/201107/04/201165.00
21 Oct 2010InterimGBX16.0031/12/200931/12/201027/10/201029/10/201006/01/2011-
21 Jul 2010InterimGBX15.0031/12/200931/12/201028/07/201030/07/201007/10/2010-
28 Apr 2010InterimGBX15.0031/12/200931/12/201005/05/201007/05/201008/07/2010-
04 Feb 2010FinalGBX18.0031/12/200831/12/200910/02/201012/02/201008/04/201061.00
29 Oct 2009QuarterlyGBX15.0031/12/200831/12/200904/11/200906/09/200907/01/2010-
30 Jul 2009QuarterlyGBX14.0031/12/200831/12/200931/07/200931/07/200908/10/200928.00
22 Apr 2009QuarterlyGBX14.0031/12/200831/12/200929/04/200901/05/200909/07/2009-
05 Feb 2009FinalGBX17.0031/12/200731/12/200811/02/200913/02/200909/04/200957.00
22 Oct 2008QuarterlyGBX14.0031/12/200731/12/200829/10/200831/10/200809/01/2008-
07 Feb 2008FinalGBX13.0031/12/200631/12/200713/02/200815/02/200810/04/200853.00
25 Jul 2007QuarterlyGBX12.0031/12/200631/12/200701/08/200703/08/200711/10/2007-
24 Apr 2007QuarterlyGBX12.0031/12/200631/12/200702/05/200704/05/200712/07/2007-
08 Feb 2007QuarterlyGBX14.0031/12/200531/12/200614/02/200616/02/200612/04/2007-
08 Feb 2007FinalGBX-31/12/200531/12/2006---48.00
26 Oct 2006QuarterlyGBX12.0031/12/200531/12/200601/11/200603/11/200604/01/2007-
26 Jul 2006QuarterlyGBX11.0031/12/200531/12/200602/08/200604/08/200605/10/2006-
27 Apr 2006QuarterlyGBX11.0031/12/200531/12/200610/05/200612/05/200606/07/2006-
08 Feb 2006FinalGBX14.0031/12/200431/12/200515/02/200617/02/200606/04/200644.00
27 Oct 2005QuarterlyGBX10.0031/12/200431/12/200502/11/200504/11/200505/01/2006-
29 Jul 2005QuarterlyGBX10.0031/12/200431/12/200503/08/200505/08/200506/10/2005-
28 Apr 2005QuarterlyGBX10.0031/12/200431/12/200511/05/200513/05/200507/07/2005-
10 Feb 2005FinalGBX12.0031/12/200331/12/200416/02/200518/02/200507/04/200542.00
28 Oct 2004QuarterlyGBX10.0031/12/200331/12/200403/11/200405/11/200406/01/2005-
27 Jul 2004QuarterlyGBX10.0031/12/200331/12/200412/05/200414/05/200401/07/2004-
27 Jul 2004QuarterlyGBX10.0031/12/200331/12/200404/08/200406/08/200430/09/2004-
12 Feb 2004FinalGBX14.0031/12/200231/12/200318/02/200420/02/200415/04/200441.00
11 Feb 2004QuarterlyGBX9.0031/12/200231/12/200329/10/200331/10/200306/01/2004-
23 Jul 2003QuarterlyGBX9.0031/12/200231/12/200330/07/200301/08/200302/10/2003-
30 Apr 2003QuarterlyGBX9.0031/12/200231/12/200307/05/200309/05/200303/07/2003-
12 Feb 2003FinalGBX13.0031/12/200131/12/200219/02/200321/02/200317/04/200340.00
23 Oct 2002QuarterlyGBX9.0030/03/200230/09/200230/10/200201/11/200203/01/2003-
24 Jul 2002QuarterlyGBX9.0030/12/200130/06/200231/07/200202/08/200203/10/2002-
25 Apr 2002QuarterlyGBX9.0001/10/200131/03/200201/05/200203/05/200204/07/2002-
14 Feb 2002FinalGBX12.0031/12/200031/12/200120/02/200222/02/200218/04/200239.00
23 Oct 2001QuarterlyGBX9.0030/09/200030/09/200131/10/200102/11/200103/01/2002-
24 Jul 2001QuarterlyGBX9.0030/06/200030/06/200101/08/200103/08/200104/10/2001-
24 Apr 2001QuarterlyGBX9.0031/03/200031/03/200102/05/200104/05/200105/07/2001-
13 Dec 2000FinalGBX23.0031/12/199931/12/200018/12/200022/12/200017/04/200138.00
27 Jul 2000InterimGBX15.0030/12/199930/06/200007/08/200011/08/200016/10/2000-
16 Feb 2000FinalGBX22.0031/12/199831/12/199928/02/200003/03/200025/05/200037.00
29 Jul 1999InterimGBX15.0030/12/199830/06/199909/08/199913/08/199901/10/1999-
18 Feb 1999FinalGBX21.0031/12/199731/12/199801/03/199905/03/199920/05/199936.00

GlaxoSmithKline Fundamentals

 31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)
turnover26,505.00100.00%23,006.00100.00%23,923.00100.00%27,889.00100.00%m
pre tax profit6,647.0025.08%2,968.0012.90%10,526.0044.00%1,939.006.95%m
attributable profit5,436.0020.51%2,756.0011.98%8,422.0035.20%912.003.27%m
retained profit1,756.006.63%-1,087.00-4.72%4,548.0019.01%-3,938.00-14.12%m
eps - basic112.50 57.30 174.30 18.80 
eps - diluted110.50 56.70 172.30 18.60 
dividends per share78.00 80.00 100.00 80.00 

GlaxoSmithKline Balance Sheet

 31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)
LSE:GSK:Liabilities+EQLSE:GSK:AssetsLSE:GSK:Liabilities+EQLSE:GSK:AssetsLSE:GSK:Liabilities+EQLSE:GSK:AssetsLSE:GSK:Liabilities+EQLSE:GSK:Assets
 31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)
ASSETS
fixed assets fixed assets8,872.0021.08%9,052.0022.27%9,668.0018.09%10,808.0018.29%m
intangibles intangibles13,488.0032.05%12,044.0029.63%21,834.0040.85%24,741.0041.88%m
fixed investments fixed investments2,636.006.26%2,404.005.91%2,652.004.96%2,692.004.56%m
current assets - other current assets - other1.000.00%1,156.002.84%46.000.09%215.000.36%m
stocks stocks3,900.009.27%4,231.0010.41%4,716.008.82%5,102.008.64%m
debtors debtors7,655.0018.19%7,426.0018.27%8,700.0016.28%10,626.0017.99%m
cash & securities cash & securities5,534.0013.15%4,338.0010.67%5,830.0010.91%4,897.008.29%m
TOTAL42,086.00100%40,651.00100%53,446.00100%59,081.00100%m
LIABILITIES
creditors - short creditors - short13,677.0032.50%13,295.0032.71%13,417.0025.10%19,001.0032.16%m
creditors - long creditors - long20,597.0048.94%22,420.0055.15%31,151.0058.28%35,117.0059.44%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL34,274.0081.44%35,715.0087.86%44,568.0083.39%54,118.0091.60%m
EQUITY
ord cap, reserves ord cap, reserves6,997.0016.63%4,263.0010.49%5,114.009.57%1,124.001.90%m
prefs, minorities prefs, minorities815.001.94%673.001.66%3,764.007.04%3,839.006.50%m
TOTAL7,812.0018.56%4,936.0012.14%8,878.0016.61%4,963.008.40%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

GlaxoSmithKline Cash Flow Statement

31 Dec 2013 (GBP)31 Dec 2014 (GBP)31 Dec 2015 (GBP)31 Dec 2016 (GBP)
Operating CF7,222.005,176.002,569.006,497.00m
Pre-Financing CF7,746.004,098.008,606.005,228.00m
Retained CF1,473.00-1,287.001,503.00-1,164.00m

GlaxoSmithKline Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V:gb D:20170625 00:25:43